Certara Products - Certara IQ Archives

Poster

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

Learn how QSP modeling enabled safe, data-driven FIH dose prediction for the trispecific T-cell activator…

Certara2025 年 12 月 16 日

Live Events

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Japan: 2026 年 2 月 26 日 - 1:00 - 5:00 pm | Korea: 2026 年 3 月 4 日, 星期三…

Certara2025 年 12 月 9 日

Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.

Certara2025 年 11 月 14 日

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

Certara2025 年 11 月 13 日

Guide

De-Risking Drug Design: How Early Feasibility Assessment Transforms Biotherapeutic Development

Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…

Certara2025 年 11 月 7 日

Publication

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…

Danielle Pillsbury2025 年 11 月 7 日

Press Release

Certara 借力 AI 驱动 QSP 平台，扩充生物模拟市场版图

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

Certara2025 年 10 月 30 日

Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…

Certara2025 年 10 月 22 日

Video

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…

Certara2025 年 10 月 16 日

Video

Immuno-oncology (IO) Simulator in Certara IQ™

Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…

Certara2025 年 10 月 16 日

Certara Products – Certara IQ

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

De-Risking Drug Design: How Early Feasibility Assessment Transforms Biotherapeutic Development

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara 借力 AI 驱动 QSP 平台，扩充生物模拟市场版图

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Immuno-oncology (IO) Simulator in Certara IQ™

订阅时事通讯

快捷链接

解决方案

联系我们